Current Drug Discovery Technologies


Vladimir P. Torchilin
(68301 citations)
Department of Pharmaceutical Science Center for Pharmaceutical Biotechnology and Nanomedicine
Northeastern University
Boston, MA 02115

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

Meet Our Editor promotion: free to download

Volume:13   Issue: 2
Pp: 58-59
Vladimir Torchilin
DOI: 10.2174/157016381302160623143936
Published on: 22 June, 2016

Drug Discovery and Development of Type 2 Diabetes Mellitus: Modern-Integrative Medicinal Approach

Volume:13   Issue: 2
Pp: 60-67
Debosree Ghosh and Pratap Parida
DOI: 10.2174/1570163813666160414105327
Published on: 22 June, 2016

Can EGFR-Tyrosine Kinase Inhibitors (TKI) Alone Without Talc Pleurodesis Prevent Recurrence of Malignant Pleural Effusion (MPE) in Lung Adenocarcinoma open access plus

Volume:13   Issue: 2
Pp: 68-76
Akash Verma, Akhil Chopra, Yeo W. Lee, Lavina D. Bharwani, Atasha B. Asmat, Dokeu B.A Aneez, Fazuludeen A. Akbar, Albert Y.H. Lim, Sanjay H. Chotirmall and John Abisheganaden
DOI: 10.2174/1570163813666160524142846
Published on: 22 June, 2016

Development and Assessment of a Gas Chromatographic Based Method for the Quantification of Thymol from Cream Based Formulation

Volume:13   Issue: 2
Pp: 77-83
Soliman Mohammadi Samani, Mahmoodreza Moein, Peyman Petramfar and Mohammad M. Zarshenas
DOI: 10.2174/1570163813666160519111145
Published on: 22 June, 2016

Quantitative Structure-Cytotoxic Activity Relationship 1-(Benzoyloxy)urea and Its Derivative open access plus

Volume:13   Issue: 2
Pp: 101-108
Suko Hardjono, Siswandono Siswodihardjo, Purwanto Pramono and Win Darmanto
DOI: 10.2174/1570163813666160525112327
Published on: 22 June, 2016

Imidazolium Ionic Liquids as Potential Anti-Candida Inhibitors: QSAR Modeling and Experimental Studies

Volume:13   Issue: 2
Pp: 109-119
Diana Hodyna, Vasyl Kovalishyn, Sergiy Rogalsky, Volodymyr Blagodatnyi and Larisa Metelytsia
DOI: 10.2174/1570163813666160510122201
Published on: 22 June, 2016